SESSION R.A. II enters TAYSHA GENE THERAPIES, INC. with 9.43M shares across direct and indirect positions
This filing by SESSION R.A. II (President and CEO) establishes the baseline for all future Form 4 insider transaction reports at TAYSHA GENE THERAPIES, INC..
Direct Indirect
Filed: 9/23/2020ACC: 0001209191-20-051744
DirectorOfficer10% Owner· President and CEO
Since Sep 2020
9.43M
Baseline shares
97% direct
9.15M
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
3
Security positions
282.18K indirect
Non-Derivative Holdings3
Common Stock
IndirectShares owned141.09K
Common Stock
DirectShares owned9.15M
Common Stock
IndirectShares owned141.09K
Total
9.15M direct·282.18K indirect9.43M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 141.09K | Indirect |
| Common Stock | 9.15M | Direct |
| Common Stock | 141.09K | Indirect |
| Total | 9.43M | 9.15M direct·282.18K indirect |
Derivative Holdings0
No derivative holdings reported